uniQure (QURE) Shares Outstanding (2015 - 2026)
uniQure (QURE) posted quarterly Shares Outstanding (Entity) of $69.3 million for Q2 2026, up 26.37% year-over-year from $54.9 million in Q2 2025, and up 10.0% quarter-over-quarter from $63.0 million in Q1 2026.
Analysis
uniQure (QURE) Shares Outstanding (2015 - 2026) Analysis & Trends
uniQure's Shares Outstanding (Entity) history runs 12 years deep, the most recent figure standing at $69.3 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 26.37% year-over-year to $69.3 million; the TTM figure through Jun 2026 stood at $69.3 million (up 26.37% YoY), while the FY2025 annual figure was $62.3 million, up 27.25% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $69.3 million, up from $63.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $69.3 million in Q2 2026, with the low at $46.6 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $48.6 million (2024), against an average of $52.2 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) advanced 1.31% in 2022, then gained 27.55% in 2025.
- uniQure's Shares Outstanding (Entity) stood at $47.0 million in 2022, then climbed by 1.84% to $47.8 million in 2023, then increased by 2.41% to $49.0 million in 2024, then rose by 27.25% to $62.3 million in 2025, then gained by 11.23% to $69.3 million in 2026.
- Business Quant data shows QURE's Shares Outstanding (Entity) at $69.3 million in Q2 2026, $63.0 million in Q1 2026, and $62.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 66.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.24 Mn |
| Mar 31, 2026 | 62.74 Mn |
| Dec 31, 2025 | 57.50 Mn |
| Sep 30, 2025 | 58.52 Mn |
| Jun 30, 2025 | 54.81 Mn |
| Mar 31, 2025 | 53.11 Mn |
| Dec 31, 2024 | 48.65 Mn |
| Sep 30, 2024 | 48.72 Mn |
| Jun 30, 2024 | 48.62 Mn |
| Mar 31, 2024 | 48.38 Mn |
| Dec 31, 2023 | 47.67 Mn |
| Sep 30, 2023 | 47.77 Mn |
| Jun 30, 2023 | 47.65 Mn |
| Mar 31, 2023 | 47.44 Mn |
| Dec 31, 2022 | 46.74 Mn |
| Sep 30, 2022 | 46.77 Mn |
| Jun 30, 2022 | 46.67 Mn |
| Mar 31, 2022 | 46.60 Mn |
| Dec 31, 2021 | 45.99 Mn |
| Sep 30, 2021 | 46.15 Mn |